Well we got some news (Estradiol tablets), but not what I had hoped for. It is a positive nevertheless. Sure is taking a long time to tell us how they are spending the recent offering monies. I am surprised the share price has held up. We better get a question about this in today's call.
I found this from the CDC which suggests something is going on behind the scenes. You need a strong analytical capability to support the use of these hormones in women.
News 
Market Data 
Discover 
